Established in 2004, Ixico’s innovative technologies help those involved in researching and treating serious diseases to make rapid decisions and improve patient outcomes. Their clinical focus is predominantly dementia, however they also support clinical studies for other disease areas in the field of neuro-degeneration and beyond. Corporateprm have been working on the annual report for a number of years and are pleased to be working with the team at Ixico again this year to produce as simple but elegant report.